These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 37268007)

  • 1. Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance.
    Oromí-Bosch A; Antani JD; Turner PE
    Annu Rev Virol; 2023 Sep; 10(1):503-524. PubMed ID: 37268007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
    Fujiki J; Nakamura K; Nakamura T; Iwano H
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation.
    Burmeister AR; Tzintzun-Tapia E; Roush C; Mangal I; Barahman R; Bjornson RD; Turner PE
    Appl Environ Microbiol; 2023 Jun; 89(6):e0007923. PubMed ID: 37191555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of evolved bacterial resistance to phage therapy.
    Torres-Barceló C; Turner PE; Buckling A
    Curr Opin Virol; 2022 Apr; 53():101201. PubMed ID: 35180532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of bacteriophages against intracellular bacteria.
    Śliwka P; Ochocka M; Skaradzińska A
    Crit Rev Microbiol; 2022 Mar; 48(2):222-239. PubMed ID: 34428105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A game of resistance: War between bacteria and phages and how phage cocktails can be the solution.
    Costa P; Pereira C; Romalde JL; Almeida A
    Virology; 2024 Nov; 599():110209. PubMed ID: 39186863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria.
    North OI; Brown ED
    Ann N Y Acad Sci; 2021 Jul; 1496(1):23-34. PubMed ID: 33175408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled Bacteriophage Therapy for Multi-Drug Resistant
    Winzig F; Gandhi S; Lee A; Würstle S; Stanley GL; Capuano I; Neuringer I; Koff JL; Turner PE; Chan BK
    Yale J Biol Med; 2022 Dec; 95(4):413-427. PubMed ID: 36568830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.